Special Report: ‘The Broad Institute’s CRISPR-Cas9 Patents'
CRISPR patents have been a hot topic around the world for a few years now, with much of the focus on Europe and the US. The picture in Japan is less well known but equally interesting. We're delighted to share with you a case study on ‘The Broad Institute’s CRISPR-Cas9 Patents’ in partnership with Abe & Partners.
Access the case study for an in-depth exploration of the dispute between the Broad Institute and the Japanese Patent Office (JPO) around genome editing technology.
Enter your details into the form now to access the special report
Use the form to download the special report
Enter your details below to access the special report now
Brought to you in association with: